cp wire

CP Wire Articles

Microbiome Report for Week Ending 2/23/19

BiomX Raises $32 Million in Series B Financing
BiomX Ltd., a microbiome company developing... read more

Thu, 02/28/19 - 09:20 pm
Evotec Receives Milestone Payment for Initiating Ph II Trials of Persistent Cough Drug

Evotec AG (OTC PINK: EVTCY) (FSE: EVTA) (XETRA: EVT) announced on 2/28/19 that a promising small molecule from its multi-target alliance with Bayer has advanced into Phase II clinical development... read more

Thu, 02/28/19 - 10:35 am
Blackstone Life Sciences and Novartis Launch Anthos Therapeutics to Develop Cardiovascular Disease Treatments

Blackstone Life Sciences today announced the launch of Anthos Therapeutics Inc. (“Anthos”), a new biopharmaceutical company focused on advancing next-generation targeted therapies for high-risk... read more

Wed, 02/27/19 - 10:14 am
Live Blog: Seven Pharma Execs Face Senate Finance Committee to Discuss Drug Pricing

This morning, starting at approximately 10:15 AM ET, the United States Senate Finance Committee is holding a special hearing on drug pricing. Going before the Committee will be seven... read more

Tue, 02/26/19 - 10:20 am
Xynomic Starts Ph III Trial of Abexinostat in Renal Cell Carcinoma

Xynomic Pharma, a clinical stage US-China oncology drug development company, and Bison Capital Acquisition Corp. (Nasdaq: BCAC) jointly announced on 2/25/19 the dosing of the first South Korean... read more

Tue, 02/26/19 - 10:02 am

Pages